Literature DB >> 17669995

Preliminary results of 130 aortic valve replacements with a new mechanical bileaflet prosthesis: the Edwards MIRA valve.

J P Remadi1, P Marticho, A Nzomvuama, A Degandt.   

Abstract

We present a series of 130 consecutive patients operated for aortic valve replacement (AVR) using the standard MIRA prosthesis between January 1999 and March 2001. Most of the patients were male (sex ratio = 2) with a mean age of 61.5 +/- 9.5 years. The prosthesis was implanted using the continuous suture technique. The mean diameter of the implanted prostheses was 23 mm. This series was composed of 66% of isolated AVR. The associated operative procedures were as follows: coronary artery bypass grafting 23%, replacement of the ascending aorta 6%, replacement of the mitral valves 8% and mitral valvuloplasty 3%. A short-term follow-up was performed and echocardiography data at 6 +/- 2.1 months were collected. Operative mortality (<30 days) was 2.32% for the isolated AVR. No structural dysfunction, endocarditis or paraprosthetic leakage were observed. Postoperative ultrasound echography at 6 months revealed a transprosthetic gradient of 14.8 +/- 4.2 mmHg for the mean prosthesis diameter of 23 mm. The Edwards MIRA prosthesis has produced satisfactory and reliable early results. Long-term follow-up will be necessary to confirm these good early results.

Entities:  

Year:  2003        PMID: 17669995     DOI: 10.1016/S1569-9293(02)00089-0

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  2 in total

1.  Long-term experience with the Sorin Bicarbon and Edwards Mira mechanical valve prostheses in the mitral position.

Authors:  Toshihiro Fukui; Toshihiko Shibata; Yasuyuki Sasaki; Hidekazu Hirai; Manabu Motoki; Yosuke Takahashi; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-03

2.  Left ventricular mass regression following implantation of MIRA bileaflet valves in patients with severe aortic stenosis.

Authors:  Stefan Toggweiler; Michel Zuber; Katharina Gerber; Reinhard Schläpfer; Paul Erne; Peter Stulz
Journal:  Heart Vessels       Date:  2009-01-23       Impact factor: 2.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.